{
  "claim_id": "claim_006",
  "claim": "Flublok is produced using a novel production platform in which recombinant HA is expressed in insect cells using a baculovirus expression vector system (BEVS).",
  "document": "CDC_Influenza_vaccines",
  "additional_evidence_check": {
    "checked_for_more": true,
    "found_additional": false,
    "additional_count": 0
  },
  "completeness_stats": {
    "existing_evidence": 2,
    "new_evidence_found": 0,
    "total_evidence": 2
  },
  "combined_evidence": [
    {
      "id": 1,
      "quote": "RIV4 (recombinant HA vaccine)",
      "relevance_explanation": "This quote identifies RIV4 as a recombinant HA vaccine, which directly supports the claim that Flublok is produced using a recombinant technology platform."
    },
    {
      "id": 2,
      "quote": "HA = hemagglutinin; IIV4 = inactivated influenza vaccine, quadrivalent; ... RIV4 (recombinant HA vaccine)",
      "relevance_explanation": "This quote defines RIV4 as a recombinant hemagglutinin vaccine, supporting the claim that Flublok is produced by expressing recombinant HA, which is a key part of the novel production platform described."
    }
  ],
  "completeness_assessment": {
    "missing_aspects": []
  },
  "model_used": "gpt-4.1"
}